July 11,2019
Grassley Statement on Withdrawal of HHS Rebate Rule
Grassley Statement on
Withdrawal of HHS Rebate Rule
“It’s Time for Congress
to Legislate”
Washington – Senate Finance Committee Chairman Chuck Grassley
(R-Iowa) today released the following statement regarding the Department of
Health and Human Services’ (HHS) withdrawal of its proposed “rebate rule.”
“I
had some concerns about the Administration’s proposed rebate rule, but
President Trump and Secretary Azar should be commended for being aggressive in
their work to lower prescription drug prices. The withdrawal puts even more
pressure on Congress to step up to the plate. It’s time for Congress to
legislate and deliver on our promise to lower health care costs for Americans.
“In
the Finance Committee, I’m working with Ranking Member Wyden and my Republican
and Democratic colleagues on a package of reforms to increase transparency and
reduce the cost of prescription drugs. While the final details are still being
negotiated, we’re on track to report a bill out of committee very soon. This
bipartisan bill will bring much-needed transparency to drug pricing, including
the role of middlemen and rebates in the system.
“The
Judiciary Committee recently passed a bill I authored that directs the Federal Trade Commission to study
the activities of PBMs and other intermediaries, including spread pricing and
reimbursements, steering and the use of formulary designs to increase market
share of higher-priced drugs. It also requires a study of the state of
competition in the health care supply chain. The Federal Trade Commission must
also provide policy recommendations to improve transparency and competition.
That will further inform next steps for Congress.
“I’m
also glad that the HELP Committee under the leadership of Chairman Alexander
and Ranking Member Murray have addressed the role of rebates in commercial
insurance by passing legislation that bans spread pricing and provides
employers with the information they need to lower drug costs for their
employees.”
“This
is all part of a concerted and bipartisan effort in the Senate to pass a
comprehensive package of health care reforms this year to save American
consumers and taxpayers from overpaying for health care.”
-30-
Next Article Previous Article